Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in the Treatment of Patients With Organic Brain Syndrome

Medical Immunology (Russia) - Russian Federation
doi 10.15789/1563-0625-2018-4-577-588
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SPb RAACI

Related search

The Protectin PCTR1 Is Produced by Human M2 Macrophages and Enhances Resolution of Infectious Inflammation

American Journal of Pathology
Forensic MedicinePathology
2016English

Studies on Cytokines Produced by Alveolar Macrophages in the Patients With Sarcoidosis

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1994English

M2 Macrophages Are Closely Associated With Accelerated Clavicle Fracture Healing in Patients With Traumatic Brain Injury: A Retrospective Cohort Study

Journal of Orthopaedic Surgery and Research
SurgeryOrthopedicsSports Medicine
2018English

Intranasal Antifungal Treatment in 51 Patients With Chronic Rhinosinusitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2002English

Intranasal Administration of PACAP: Uptake by Brain and Regional Brain Targeting With Cyclodextrins

Peptides
BiochemistryEndocrinologyPhysiologyCellularMolecular Neuroscience
2012English

M2 Polarization Enhances Silica Nanoparticle Uptake by Macrophages

Frontiers in Pharmacology
Pharmacology
2015English

156 Improvement in Disease Severity in Patients With Treatment-Resistant Depression Following Treatment With Intranasal Esketamine

CNS Spectrums
PsychiatryMental HealthNeurology
2018English

Treatment of Patients With the Hypereosinophilic Syndrome With Mepolizumab

New England Journal of Medicine
Medicine
2008English

Characteristics and Potential Role of M2 Macrophages in COPD

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy